中国拒绝丙型肝炎药物索非布韦的专利。 - Suppr

Suppr

超能文献

China rejects patent on hepatitis C drug sofosbuvir.

作者信息

Kmietowicz Zosia

机构信息

The BMJ.

出版信息

BMJ. 2015 Jun 23;350:h3429. doi: 10.1136/bmj.h3429.

DOI:10.1136/bmj.h3429

PMID:26105994

Abstract

摘要

相似文献

China rejects patent on hepatitis C drug sofosbuvir.

BMJ. 2015 Jun 23;350:h3429. doi: 10.1136/bmj.h3429.

Guideline: New HCV drugs should go to sickest patients.

JAMA. 2014 Sep 17;312(11):1084-5. doi: 10.1001/jama.2014.11373.

WHO issues guidelines on HCV amid drug cost controversy.

JAMA. 2014 Jun 11;311(22):2262-3. doi: 10.1001/jama.2014.5277.

Dare to refuse the exorbitant price of Sovaldi!

Prescrire Int. 2014 Nov;23(154):278.

Screening urged for hepatitis C but drug costs are prohibitive.

CMAJ. 2014 Mar 18;186(5):329. doi: 10.1503/cmaj.109-4727. Epub 2014 Feb 18.

Campaigners challenge patent applications for hepatitis C drug in five countries.

BMJ. 2015 Jun 1;350:h2938. doi: 10.1136/bmj.h2938.

Medicine. Hepatitis C can be cured globally, but at what cost?

Science. 2014 Jul 11;345(6193):141-2. doi: 10.1126/science.1257737.

US health insurers say Gilead hepatitis C drug too costly.

Clin Infect Dis. 2014 Jul 15;59(2):i-ii.

Payers consider waiting out budget-busting hepatitis C drug.

Manag Care. 2014 May;23(5):7, 9.

Pharmaceuticals. Advocates protest the cost of a hepatitis C cure.

Science. 2013 Dec 13;342(6164):1302-3. doi: 10.1126/science.342.6164.1302.

引用本文的文献

Treatment advocate tactics to expand access to antiviral therapy for HIV and viral hepatitis C in low- to high-income settings: making sure no one is left behind.

J Int AIDS Soc. 2018 Apr;21 Suppl 2(Suppl Suppl 2):e25060. doi: 10.1002/jia2.25060.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

China rejects patent on hepatitis C drug sofosbuvir.

作者信息

Kmietowicz Zosia

机构信息

The BMJ.

出版信息

BMJ. 2015 Jun 23;350:h3429. doi: 10.1136/bmj.h3429.

DOI:10.1136/bmj.h3429

PMID:26105994

Abstract

摘要

相似文献

China rejects patent on hepatitis C drug sofosbuvir.

BMJ. 2015 Jun 23;350:h3429. doi: 10.1136/bmj.h3429.

Guideline: New HCV drugs should go to sickest patients.

JAMA. 2014 Sep 17;312(11):1084-5. doi: 10.1001/jama.2014.11373.

WHO issues guidelines on HCV amid drug cost controversy.

JAMA. 2014 Jun 11;311(22):2262-3. doi: 10.1001/jama.2014.5277.

Dare to refuse the exorbitant price of Sovaldi!

Prescrire Int. 2014 Nov;23(154):278.

Screening urged for hepatitis C but drug costs are prohibitive.

CMAJ. 2014 Mar 18;186(5):329. doi: 10.1503/cmaj.109-4727. Epub 2014 Feb 18.

Campaigners challenge patent applications for hepatitis C drug in five countries.

BMJ. 2015 Jun 1;350:h2938. doi: 10.1136/bmj.h2938.

Medicine. Hepatitis C can be cured globally, but at what cost?

Science. 2014 Jul 11;345(6193):141-2. doi: 10.1126/science.1257737.

US health insurers say Gilead hepatitis C drug too costly.

Clin Infect Dis. 2014 Jul 15;59(2):i-ii.

Payers consider waiting out budget-busting hepatitis C drug.

Manag Care. 2014 May;23(5):7, 9.

Pharmaceuticals. Advocates protest the cost of a hepatitis C cure.

Science. 2013 Dec 13;342(6164):1302-3. doi: 10.1126/science.342.6164.1302.

引用本文的文献

Treatment advocate tactics to expand access to antiviral therapy for HIV and viral hepatitis C in low- to high-income settings: making sure no one is left behind.

J Int AIDS Soc. 2018 Apr;21 Suppl 2(Suppl Suppl 2):e25060. doi: 10.1002/jia2.25060.